ArticleOncotarget2018

Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemia.

Joachim R Göthert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.